Journal article
microRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma
Blood, Vol.122(12), pp.2083-2092
09/19/2013
DOI: 10.1182/blood-2012-08-447375
PMCID: PMC3778551
PMID: 23801630
Abstract
Anaplastic large-cell lymphoma has a unique miRNA signature.
The miR-17∼92 is an important downstream effector of ALK oncogenic pathway.
Anaplastic large-cell lymphomas (ALCLs) encompass at least 2 systemic diseases distinguished by the presence or absence of anaplastic lymphoma kinase (ALK) expression. We performed genome-wide microRNA (miRNA) profiling on 33 ALK-positive (ALK[+]) ALCLs, 25 ALK-negative (ALK[−]) ALCLs, 9 angioimmunoblastic T-cell lymphomas, 11 peripheral T-cell lymphomas not otherwise specified (PTCLNOS), and normal T cells, and demonstrated that ALCLs express many of the miRNAs that are highly expressed in normal T cells with the prominent exception of miR-146a. Unsupervised hierarchical clustering demonstrated distinct clustering of ALCL, PTCL-NOS, and the AITL subtype of PTCL. Cases of ALK(+) ALCL and ALK(–) ALCL were interspersed in unsupervised analysis, suggesting a close relationship at the molecular level. We identified an miRNA signature of 7 miRNAs (5 upregulated: miR-512-3p, miR-886-5p, miR-886-3p, miR-708, miR-135b; 2 downregulated: miR-146a, miR-155) significantly associated with ALK(+) ALCL cases. In addition, we derived an 11-miRNA signature (4 upregulated: miR-210, miR-197, miR-191, miR-512-3p; 7 downregulated: miR-451, miR-146a, miR-22, miR-455-3p, miR-455-5p, miR-143, miR-494) that differentiates ALK(–) ALCL from other PTCLs. Our in vitro studies identified a set of 32 miRNAs associated with ALK expression. Of these, the miR-17∼92 cluster and its paralogues were also highly expressed in ALK(+) ALCL and may represent important downstream effectors of the ALK oncogenic pathway.
Details
- Title: Subtitle
- microRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma
- Creators
- Cuiling Liu - Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NEJaveed Iqbal - Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NEJulie Teruya-Feldstein - Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NYYulei Shen - Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NEMagdalena Julia Dabrowska - Department of Hematology, Aalborg Hospital, University of Aarhus, Aarhus, DenmarkKaren Dybkaer - Department of Hematology, Aalborg Hospital, University of Aarhus, Aarhus, DenmarkMegan S Lim - Department of Pathology, University of Michigan Health System, Ann Arbor, MIRoberto Piva - Department of Molecular Biotechnology and Health Sciences, and Center for Experimental Research and Medical Studies, University of Torino, Torino, Italy; andAntonella Barreca - Department of Molecular Biotechnology and Health Sciences, and Center for Experimental Research and Medical Studies, University of Torino, Torino, Italy; andElisa Pellegrino - Department of Molecular Biotechnology and Health Sciences, and Center for Experimental Research and Medical Studies, University of Torino, Torino, Italy; andElisa Spaccarotella - Department of Molecular Biotechnology and Health Sciences, and Center for Experimental Research and Medical Studies, University of Torino, Torino, Italy; andCynthia M Lachel - Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NECan Kucuk - Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NEChun-Sun Jiang - Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NEXiaozhou Hu - Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NESharathkumar Bhagavathi - Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NETimothy C Greiner - Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NEDennis D Weisenburger - Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NEPatricia Aoun - Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NESherrie L Perkins - Department of Pathology, University of Utah, Salt Lake City, UTTimothy W McKeithan - Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NEGiorgio Inghirami - Department of Molecular Biotechnology and Health Sciences, and Center for Experimental Research and Medical Studies, University of Torino, Torino, Italy; andWing C Chan - Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE
- Resource Type
- Journal article
- Publication Details
- Blood, Vol.122(12), pp.2083-2092
- DOI
- 10.1182/blood-2012-08-447375
- PMID
- 23801630
- PMCID
- PMC3778551
- NLM abbreviation
- Blood
- ISSN
- 0006-4971
- eISSN
- 1528-0020
- Publisher
- American Society of Hematology; Washington, DC
- Grant note
- National Institutes of Health
- Language
- English
- Date published
- 09/19/2013
- Academic Unit
- Pathology
- Record Identifier
- 9984047635802771
Metrics
11 Record Views